1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Lewy Body Dementia Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Modafinil 1.2.3 Benzodiazepine 1.2.4 Antidepressants 1.2.5 Cholinesterase Inhibitors 1.2.6 Antipsychotic Drugs 1.2.7 Carbidopa-Levodopa 1.3 Market by Application 1.3.1 Global Lewy Body Dementia Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Lewy Body Dementia Drugs Market Perspective (2016-2027) 2.2 Lewy Body Dementia Drugs Growth Trends by Regions 2.2.1 Lewy Body Dementia Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Lewy Body Dementia Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Lewy Body Dementia Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Lewy Body Dementia Drugs Industry Dynamic 2.3.1 Lewy Body Dementia Drugs Market Trends 2.3.2 Lewy Body Dementia Drugs Market Drivers 2.3.3 Lewy Body Dementia Drugs Market Challenges 2.3.4 Lewy Body Dementia Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Lewy Body Dementia Drugs Players by Revenue 3.1.1 Global Top Lewy Body Dementia Drugs Players by Revenue (2016-2021) 3.1.2 Global Lewy Body Dementia Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Lewy Body Dementia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Lewy Body Dementia Drugs Revenue 3.4 Global Lewy Body Dementia Drugs Market Concentration Ratio 3.4.1 Global Lewy Body Dementia Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Lewy Body Dementia Drugs Revenue in 2020 3.5 Lewy Body Dementia Drugs Key Players Head office and Area Served 3.6 Key Players Lewy Body Dementia Drugs Product Solution and Service 3.7 Date of Enter into Lewy Body Dementia Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Lewy Body Dementia Drugs Breakdown Data by Type 4.1 Global Lewy Body Dementia Drugs Historic Market Size by Type (2016-2021) 4.2 Global Lewy Body Dementia Drugs Forecasted Market Size by Type (2022-2027) 5 Lewy Body Dementia Drugs Breakdown Data by Application 5.1 Global Lewy Body Dementia Drugs Historic Market Size by Application (2016-2021) 5.2 Global Lewy Body Dementia Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Lewy Body Dementia Drugs Market Size (2016-2027) 6.2 North America Lewy Body Dementia Drugs Market Size by Type 6.2.1 North America Lewy Body Dementia Drugs Market Size by Type (2016-2021) 6.2.2 North America Lewy Body Dementia Drugs Market Size by Type (2022-2027) 6.2.3 North America Lewy Body Dementia Drugs Market Size by Type (2016-2027) 6.3 North America Lewy Body Dementia Drugs Market Size by Application 6.3.1 North America Lewy Body Dementia Drugs Market Size by Application (2016-2021) 6.3.2 North America Lewy Body Dementia Drugs Market Size by Application (2022-2027) 6.3.3 North America Lewy Body Dementia Drugs Market Size by Application (2016-2027) 6.4 North America Lewy Body Dementia Drugs Market Size by Country 6.4.1 North America Lewy Body Dementia Drugs Market Size by Country (2016-2021) 6.4.2 North America Lewy Body Dementia Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Lewy Body Dementia Drugs Market Size (2016-2027) 7.2 Europe Lewy Body Dementia Drugs Market Size by Type 7.2.1 Europe Lewy Body Dementia Drugs Market Size by Type (2016-2021) 7.2.2 Europe Lewy Body Dementia Drugs Market Size by Type (2022-2027) 7.2.3 Europe Lewy Body Dementia Drugs Market Size by Type (2016-2027) 7.3 Europe Lewy Body Dementia Drugs Market Size by Application 7.3.1 Europe Lewy Body Dementia Drugs Market Size by Application (2016-2021) 7.3.2 Europe Lewy Body Dementia Drugs Market Size by Application (2022-2027) 7.3.3 Europe Lewy Body Dementia Drugs Market Size by Application (2016-2027) 7.4 Europe Lewy Body Dementia Drugs Market Size by Country 7.4.1 Europe Lewy Body Dementia Drugs Market Size by Country (2016-2021) 7.4.2 Europe Lewy Body Dementia Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Lewy Body Dementia Drugs Market Size (2016-2027) 8.2 Asia-Pacific Lewy Body Dementia Drugs Market Size by Type 8.2.1 Asia-Pacific Lewy Body Dementia Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Lewy Body Dementia Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Lewy Body Dementia Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Lewy Body Dementia Drugs Market Size by Application 8.3.1 Asia-Pacific Lewy Body Dementia Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Lewy Body Dementia Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Lewy Body Dementia Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Lewy Body Dementia Drugs Market Size by Region 8.4.1 Asia-Pacific Lewy Body Dementia Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Lewy Body Dementia Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Lewy Body Dementia Drugs Market Size (2016-2027) 9.2 Latin America Lewy Body Dementia Drugs Market Size by Type 9.2.1 Latin America Lewy Body Dementia Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Lewy Body Dementia Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Lewy Body Dementia Drugs Market Size by Type (2016-2027) 9.3 Latin America Lewy Body Dementia Drugs Market Size by Application 9.3.1 Latin America Lewy Body Dementia Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Lewy Body Dementia Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Lewy Body Dementia Drugs Market Size by Application (2016-2027) 9.4 Latin America Lewy Body Dementia Drugs Market Size by Country 9.4.1 Latin America Lewy Body Dementia Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Lewy Body Dementia Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Lewy Body Dementia Drugs Market Size (2016-2027) 10.2 Middle East & Africa Lewy Body Dementia Drugs Market Size by Type 10.2.1 Middle East & Africa Lewy Body Dementia Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Lewy Body Dementia Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Lewy Body Dementia Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Lewy Body Dementia Drugs Market Size by Application 10.3.1 Middle East & Africa Lewy Body Dementia Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Lewy Body Dementia Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Lewy Body Dementia Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Lewy Body Dementia Drugs Market Size by Country 10.4.1 Middle East & Africa Lewy Body Dementia Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Lewy Body Dementia Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Lewy Body Dementia Drugs Introduction 11.1.4 Novartis Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Lewy Body Dementia Drugs Introduction 11.2.4 Pfizer Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.2.5 Pfizer Recent Development 11.3 Bayer 11.3.1 Bayer Company Details 11.3.2 Bayer Business Overview 11.3.3 Bayer Lewy Body Dementia Drugs Introduction 11.3.4 Bayer Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.3.5 Bayer Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Lewy Body Dementia Drugs Introduction 11.4.4 GlaxoSmithKline Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.4.5 GlaxoSmithKline Recent Development 11.5 Mylan 11.5.1 Mylan Company Details 11.5.2 Mylan Business Overview 11.5.3 Mylan Lewy Body Dementia Drugs Introduction 11.5.4 Mylan Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.5.5 Mylan Recent Development 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Lewy Body Dementia Drugs Introduction 11.6.4 Sanofi Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.6.5 Sanofi Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Details 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Lewy Body Dementia Drugs Introduction 11.7.4 Johnson & Johnson Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.7.5 Johnson & Johnson Recent Development 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Details 11.8.2 Teva Pharmaceuticals Business Overview 11.8.3 Teva Pharmaceuticals Lewy Body Dementia Drugs Introduction 11.8.4 Teva Pharmaceuticals Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.8.5 Teva Pharmaceuticals Recent Development 11.9 Eli Lilly 11.9.1 Eli Lilly Company Details 11.9.2 Eli Lilly Business Overview 11.9.3 Eli Lilly Lewy Body Dementia Drugs Introduction 11.9.4 Eli Lilly Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.9.5 Eli Lilly Recent Development 11.10 Eisai 11.10.1 Eisai Company Details 11.10.2 Eisai Business Overview 11.10.3 Eisai Lewy Body Dementia Drugs Introduction 11.10.4 Eisai Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.10.5 Eisai Recent Development 11.11 Takeda Pharmaceutical 11.11.1 Takeda Pharmaceutical Company Details 11.11.2 Takeda Pharmaceutical Business Overview 11.11.3 Takeda Pharmaceutical Lewy Body Dementia Drugs Introduction 11.11.4 Takeda Pharmaceutical Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.11.5 Takeda Pharmaceutical Recent Development 11.12 Allergan 11.12.1 Allergan Company Details 11.12.2 Allergan Business Overview 11.12.3 Allergan Lewy Body Dementia Drugs Introduction 11.12.4 Allergan Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.12.5 Allergan Recent Development 11.13 Bausch Health Companies 11.13.1 Bausch Health Companies Company Details 11.13.2 Bausch Health Companies Business Overview 11.13.3 Bausch Health Companies Lewy Body Dementia Drugs Introduction 11.13.4 Bausch Health Companies Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.13.5 Bausch Health Companies Recent Development 11.14 BioArctic 11.14.1 BioArctic Company Details 11.14.2 BioArctic Business Overview 11.14.3 BioArctic Lewy Body Dementia Drugs Introduction 11.14.4 BioArctic Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.14.5 BioArctic Recent Development 11.15 Sumitomo Dainippon Pharma 11.15.1 Sumitomo Dainippon Pharma Company Details 11.15.2 Sumitomo Dainippon Pharma Business Overview 11.15.3 Sumitomo Dainippon Pharma Lewy Body Dementia Drugs Introduction 11.15.4 Sumitomo Dainippon Pharma Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.15.5 Sumitomo Dainippon Pharma Recent Development 11.16 Jazz Pharmaceuticals 11.16.1 Jazz Pharmaceuticals Company Details 11.16.2 Jazz Pharmaceuticals Business Overview 11.16.3 Jazz Pharmaceuticals Lewy Body Dementia Drugs Introduction 11.16.4 Jazz Pharmaceuticals Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.16.5 Jazz Pharmaceuticals Recent Development 11.17 Hisamitsu Pharmaceutical 11.17.1 Hisamitsu Pharmaceutical Company Details 11.17.2 Hisamitsu Pharmaceutical Business Overview 11.17.3 Hisamitsu Pharmaceutical Lewy Body Dementia Drugs Introduction 11.17.4 Hisamitsu Pharmaceutical Revenue in Lewy Body Dementia Drugs Business (2016-2021) 11.17.5 Hisamitsu Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Lewy Body Dementia Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Modafinil Table 3. Key Players of Benzodiazepine Table 4. Key Players of Antidepressants Table 5. Key Players of Cholinesterase Inhibitors Table 6. Key Players of Antipsychotic Drugs Table 7. Key Players of Carbidopa-Levodopa Table 8. Global Lewy Body Dementia Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Lewy Body Dementia Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Lewy Body Dementia Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Lewy Body Dementia Drugs Market Share by Regions (2016-2021) Table 12. Global Lewy Body Dementia Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Lewy Body Dementia Drugs Market Share by Regions (2022-2027) Table 14. Lewy Body Dementia Drugs Market Trends Table 15. Lewy Body Dementia Drugs Market Drivers Table 16. Lewy Body Dementia Drugs Market Challenges Table 17. Lewy Body Dementia Drugs Market Restraints Table 18. Global Lewy Body Dementia Drugs Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Lewy Body Dementia Drugs Market Share by Players (2016-2021) Table 20. Global Top Lewy Body Dementia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lewy Body Dementia Drugs as of 2020) Table 21. Ranking of Global Top Lewy Body Dementia Drugs Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Lewy Body Dementia Drugs Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Lewy Body Dementia Drugs Product Solution and Service Table 25. Date of Enter into Lewy Body Dementia Drugs Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Lewy Body Dementia Drugs Market Size by Type (2016-2021) (US$ Million) Table 28. Global Lewy Body Dementia Drugs Revenue Market Share by Type (2016-2021) Table 29. Global Lewy Body Dementia Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Lewy Body Dementia Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Lewy Body Dementia Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Lewy Body Dementia Drugs Revenue Market Share by Application (2016-2021) Table 33. Global Lewy Body Dementia Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Lewy Body Dementia Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Lewy Body Dementia Drugs Market Size by Type (2016-2021) (US$ Million) Table 36. North America Lewy Body Dementia Drugs Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Lewy Body Dementia Drugs Market Size by Application (2016-2021) (US$ Million) Table 38. North America Lewy Body Dementia Drugs Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Lewy Body Dementia Drugs Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Lewy Body Dementia Drugs Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Lewy Body Dementia Drugs Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Lewy Body Dementia Drugs Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Lewy Body Dementia Drugs Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Lewy Body Dementia Drugs Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Lewy Body Dementia Drugs Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Lewy Body Dementia Drugs Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Lewy Body Dementia Drugs Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Lewy Body Dementia Drugs Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Lewy Body Dementia Drugs Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Lewy Body Dementia Drugs Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Lewy Body Dementia Drugs Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Lewy Body Dementia Drugs Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Lewy Body Dementia Drugs Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Lewy Body Dementia Drugs Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Lewy Body Dementia Drugs Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Lewy Body Dementia Drugs Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Lewy Body Dementia Drugs Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Lewy Body Dementia Drugs Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Lewy Body Dementia Drugs Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Lewy Body Dementia Drugs Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Lewy Body Dementia Drugs Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Lewy Body Dementia Drugs Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Lewy Body Dementia Drugs Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Lewy Body Dementia Drugs Market Size by Country (2022-2027) & (US$ Million) Table 65. Novartis Company Details Table 66. Novartis Business Overview Table 67. Novartis Lewy Body Dementia Drugs Product Table 68. Novartis Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 69. Novartis Recent Development Table 70. Pfizer Company Details Table 71. Pfizer Business Overview Table 72. Pfizer Lewy Body Dementia Drugs Product Table 73. Pfizer Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 74. Pfizer Recent Development Table 75. Bayer Company Details Table 76. Bayer Business Overview Table 77. Bayer Lewy Body Dementia Drugs Product Table 78. Bayer Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 79. Bayer Recent Development Table 80. GlaxoSmithKline Company Details Table 81. GlaxoSmithKline Business Overview Table 82. GlaxoSmithKline Lewy Body Dementia Drugs Product Table 83. GlaxoSmithKline Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 84. GlaxoSmithKline Recent Development Table 85. Mylan Company Details Table 86. Mylan Business Overview Table 87. Mylan Lewy Body Dementia Drugs Product Table 88. Mylan Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 89. Mylan Recent Development Table 90. Sanofi Company Details Table 91. Sanofi Business Overview Table 92. Sanofi Lewy Body Dementia Drugs Product Table 93. Sanofi Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 94. Sanofi Recent Development Table 95. Johnson & Johnson Company Details Table 96. Johnson & Johnson Business Overview Table 97. Johnson & Johnson Lewy Body Dementia Drugs Product Table 98. Johnson & Johnson Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 99. Johnson & Johnson Recent Development Table 100. Teva Pharmaceuticals Company Details Table 101. Teva Pharmaceuticals Business Overview Table 102. Teva Pharmaceuticals Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 103. Teva Pharmaceuticals Recent Development Table 104. Eli Lilly Company Details Table 105. Eli Lilly Business Overview Table 106. Eli Lilly Lewy Body Dementia Drugs Product Table 107. Eli Lilly Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 108. Eli Lilly Recent Development Table 109. Eisai Company Details Table 110. Eisai Business Overview Table 111. Eisai Lewy Body Dementia Drugs Product Table 112. Eisai Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 113. Eisai Recent Development Table 114. Takeda Pharmaceutical Company Details Table 115. Takeda Pharmaceutical Business Overview Table 116. Takeda Pharmaceutical Lewy Body Dementia Drugs Product Table 117. Takeda Pharmaceutical Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 118. Takeda Pharmaceutical Recent Development Table 119. Allergan Company Details Table 120. Allergan Business Overview Table 121. Allergan Lewy Body Dementia Drugs Product Table 122. Allergan Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 123. Allergan Recent Development Table 124. Bausch Health Companies Company Details Table 125. Bausch Health Companies Business Overview Table 126. Bausch Health Companies Lewy Body Dementia Drugs Product Table 127. Bausch Health Companies Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 128. Bausch Health Companies Recent Development Table 129. BioArctic Company Details Table 130. BioArctic Business Overview Table 131. BioArctic Lewy Body Dementia Drugs Product Table 132. BioArctic Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 133. BioArctic Recent Development Table 134. Sumitomo Dainippon Pharma Company Details Table 135. Sumitomo Dainippon Pharma Business Overview Table 136. Sumitomo Dainippon Pharma Lewy Body Dementia Drugs Product Table 137. Sumitomo Dainippon Pharma Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 138. Sumitomo Dainippon Pharma Recent Development Table 139. Jazz Pharmaceuticals Company Details Table 140. Jazz Pharmaceuticals Business Overview Table 141. Jazz Pharmaceuticals Lewy Body Dementia Drugs Product Table 142. Jazz Pharmaceuticals Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 143. Jazz Pharmaceuticals Recent Development Table 144. Hisamitsu Pharmaceutical Company Details Table 145. Hisamitsu Pharmaceutical Business Overview Table 146. Hisamitsu Pharmaceutical Lewy Body Dementia Drugs Product Table 147. Hisamitsu Pharmaceutical Revenue in Lewy Body Dementia Drugs Business (2016-2021) & (US$ Million) Table 148. Hisamitsu Pharmaceutical Recent Development Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Global Lewy Body Dementia Drugs Market Share by Type: 2020 VS 2027 Figure 2. Modafinil Features Figure 3. Benzodiazepine Features Figure 4. Antidepressants Features Figure 5. Cholinesterase Inhibitors Features Figure 6. Antipsychotic Drugs Features Figure 7. Carbidopa-Levodopa Features Figure 8. Global Lewy Body Dementia Drugs Market Share by Application: 2020 VS 2027 Figure 9. Hospital Pharmacies Case Studies Figure 10. Retail Pharmacies Case Studies Figure 11. Online Pharmacies Case Studies Figure 12. Lewy Body Dementia Drugs Report Years Considered Figure 13. Global Lewy Body Dementia Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Lewy Body Dementia Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Lewy Body Dementia Drugs Market Share by Regions: 2020 VS 2027 Figure 16. Global Lewy Body Dementia Drugs Market Share by Regions (2022-2027) Figure 17. Global Lewy Body Dementia Drugs Market Share by Players in 2020 Figure 18. Global Top Lewy Body Dementia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lewy Body Dementia Drugs as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Lewy Body Dementia Drugs Revenue in 2020 Figure 20. Global Lewy Body Dementia Drugs Revenue Market Share by Type (2016-2021) Figure 21. Global Lewy Body Dementia Drugs Revenue Market Share by Type (2022-2027) Figure 22. North America Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Lewy Body Dementia Drugs Market Share by Type (2016-2027) Figure 24. North America Lewy Body Dementia Drugs Market Share by Application (2016-2027) Figure 25. North America Lewy Body Dementia Drugs Market Share by Country (2016-2027) Figure 26. United States Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Lewy Body Dementia Drugs Market Share by Type (2016-2027) Figure 30. Europe Lewy Body Dementia Drugs Market Share by Application (2016-2027) Figure 31. Europe Lewy Body Dementia Drugs Market Share by Country (2016-2027) Figure 32. Germany Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Lewy Body Dementia Drugs Market Share by Type (2016-2027) Figure 40. Asia-Pacific Lewy Body Dementia Drugs Market Share by Application (2016-2027) Figure 41. Asia-Pacific Lewy Body Dementia Drugs Market Share by Region (2016-2027) Figure 42. China Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Lewy Body Dementia Drugs Market Share by Type (2016-2027) Figure 50. Latin America Lewy Body Dementia Drugs Market Share by Application (2016-2027) Figure 51. Latin America Lewy Body Dementia Drugs Market Share by Country (2016-2027) Figure 52. Mexico Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Lewy Body Dementia Drugs Market Share by Type (2016-2027) Figure 56. Middle East & Africa Lewy Body Dementia Drugs Market Share by Application (2016-2027) Figure 57. Middle East & Africa Lewy Body Dementia Drugs Market Share by Country (2016-2027) Figure 58. Turkey Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Lewy Body Dementia Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Novartis Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 63. Bayer Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 64. GlaxoSmithKline Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 65. Mylan Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 66. Sanofi Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 67. Johnson & Johnson Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 68. Teva Pharmaceuticals Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 69. Eli Lilly Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 70. Eisai Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 71. Takeda Pharmaceutical Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 72. Allergan Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 73. Bausch Health Companies Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 74. BioArctic Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 75. Sumitomo Dainippon Pharma Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 76. Jazz Pharmaceuticals Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 77. Hisamitsu Pharmaceutical Revenue Growth Rate in Lewy Body Dementia Drugs Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Novartis Pfizer Bayer GlaxoSmithKline Mylan Sanofi Johnson & Johnson Teva Pharmaceuticals Eli Lilly Eisai Takeda Pharmaceutical Allergan Bausch Health Companies BioArctic Sumitomo Dainippon Pharma Jazz Pharmaceuticals Hisamitsu Pharmaceutical